Cargando…

Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes

Background: Some results exist on fetuin-A as marker for vascular disease in type 2diabetes. We examined the relationship between serum fetuin-A with some factors, in patients with type 2 diabetes mellitus (T2DM). Methods: From October 2012 to June 2013, a total of 131 T2DM patients were recruited a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shidfar, Farzad, Zarrati, Mitra, Khamseh, Mohamad Ebrahim, Haghighat, Neda, Rostami, Ali, Zolfaghari, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301224/
https://www.ncbi.nlm.nih.gov/pubmed/25664301
_version_ 1782353628127821824
author Shidfar, Farzad
Zarrati, Mitra
Khamseh, Mohamad Ebrahim
Haghighat, Neda
Rostami, Ali
Zolfaghari, Hamid
author_facet Shidfar, Farzad
Zarrati, Mitra
Khamseh, Mohamad Ebrahim
Haghighat, Neda
Rostami, Ali
Zolfaghari, Hamid
author_sort Shidfar, Farzad
collection PubMed
description Background: Some results exist on fetuin-A as marker for vascular disease in type 2diabetes. We examined the relationship between serum fetuin-A with some factors, in patients with type 2 diabetes mellitus (T2DM). Methods: From October 2012 to June 2013, a total of 131 T2DM patients were recruited and evaluated for various parameters including HOMA-IR, Apo-A1, Apo-B100, body fat percentage and waist circumference. Serum fetuin-A levels were measured by enzyme-linkedimmunosorbent assay (ELISA), and Serum glucose with a Cobas MIRA analyzer by enzymatic method. Apo-B100 and apo-A1 were measured by immunoturbidimetry with a Cobas MIRA analyzer. HOMA-IR was calculated by the following formula: [fasting insulin (uIU/mL) × fasting blood glucose (mmol/L)]/22.5. Results: The mean levels of HOMA-IR were significantly increased progressively across fetuin-A tertiles (p for trend=0.04) in women but not men. Fetuin-A had just a significant positive correlation with Apo- A1(r=0.22, p=0.02). Conclusion: This present study showed that levels of serum fetuin-A are significantly associated with insulin resistance in women with T2DM.
format Online
Article
Text
id pubmed-4301224
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-43012242015-02-06 Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes Shidfar, Farzad Zarrati, Mitra Khamseh, Mohamad Ebrahim Haghighat, Neda Rostami, Ali Zolfaghari, Hamid Med J Islam Repub Iran Original Article Background: Some results exist on fetuin-A as marker for vascular disease in type 2diabetes. We examined the relationship between serum fetuin-A with some factors, in patients with type 2 diabetes mellitus (T2DM). Methods: From October 2012 to June 2013, a total of 131 T2DM patients were recruited and evaluated for various parameters including HOMA-IR, Apo-A1, Apo-B100, body fat percentage and waist circumference. Serum fetuin-A levels were measured by enzyme-linkedimmunosorbent assay (ELISA), and Serum glucose with a Cobas MIRA analyzer by enzymatic method. Apo-B100 and apo-A1 were measured by immunoturbidimetry with a Cobas MIRA analyzer. HOMA-IR was calculated by the following formula: [fasting insulin (uIU/mL) × fasting blood glucose (mmol/L)]/22.5. Results: The mean levels of HOMA-IR were significantly increased progressively across fetuin-A tertiles (p for trend=0.04) in women but not men. Fetuin-A had just a significant positive correlation with Apo- A1(r=0.22, p=0.02). Conclusion: This present study showed that levels of serum fetuin-A are significantly associated with insulin resistance in women with T2DM. Iran University of Medical Sciences 2014-09-20 /pmc/articles/PMC4301224/ /pubmed/25664301 Text en © 2014 Iran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Shidfar, Farzad
Zarrati, Mitra
Khamseh, Mohamad Ebrahim
Haghighat, Neda
Rostami, Ali
Zolfaghari, Hamid
Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title_full Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title_fullStr Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title_full_unstemmed Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title_short Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes
title_sort relationship between serum levels of fetuin-a with apo-a1, apo-b100, body composition and insulin resistance in patients with type 2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301224/
https://www.ncbi.nlm.nih.gov/pubmed/25664301
work_keys_str_mv AT shidfarfarzad relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes
AT zarratimitra relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes
AT khamsehmohamadebrahim relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes
AT haghighatneda relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes
AT rostamiali relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes
AT zolfagharihamid relationshipbetweenserumlevelsoffetuinawithapoa1apob100bodycompositionandinsulinresistanceinpatientswithtype2diabetes